Immunology and Allergology >>>> Hepatitis A vaccine
Hepatitis A vaccine.
Vaccination against hepatitis A is recommended in those countries (regions) with an average degree of endemicity, where most of the adult population is susceptible to the hepatitis A virus or people traveling to regions with high endemicity to hepatitis A. At age, he has been ill with asymptomatic hepatitis A and he develops lifelong immunity to this disease.
There are several inactivated hepatitis A vaccines that are used to vaccinate children, adolescents and adults. These vaccines are not licensed for use in children under one year of age. These include Havrix-1440 for adults and Havrix-720 for children (made in Great Britain), Algavak-M (made in Russia), Avaxim (made in France), Vakta (made in the USA), GEP-A -in-VAK (made in Russia).
Vaccination against hepatitis A is given in two doses with an interval of 6 months to 18 months between injections. The vaccine is administered parenterally. Vaccines can be given in parallel with other vaccines that make up the immunization program.
Side effects, in addition to purely individual intolerance or allergy to any component of the vaccine, may include headache, nausea, swelling, redness of the vaccine injection site.
Contraindications to vaccination: general weakness, acute illness, the height of a chronic illness, pregnancy. With caution and according to indications, the vaccine is used for liver diseases.
Read
Read